Concord Medical Files 2019 Annual Report on Form 20-F
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research, education and prevention by operating a network of medically advanced comprehensive cancer hospitals and st
PR Newswire · 04/30 22:00
Concord Medical Welcomes RMB700 Million Investment
PR Newswire · 03/11 08:40
When Will Concord Medical Services Holdings Limited (NYSE:CCM) Turn A Profit?
Simply Wall St. · 03/04 12:27
Comcast: 5%+ Correction Post Q4 Results Not Justified: Reiterate Buy
Seeking Alpha - Article · 01/24 20:48
Comcast -1.2% as UBS sees investments weighing growth
Seeking Alpha - Article · 01/24 14:30
Here are the biggest analyst calls of the day: Alphabet, Apple, PayPal, Intel & more
Here are the biggest calls on Wall Street on Friday
CNBC.com · 01/24 14:01
ClearBridge Multi Cap Growth Strategy Portfolio Manager Commentary Q4 2019
Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company's segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China. Its network consists of approximately 130 cooperative centers based in over 70 hospitals, spanning approximately 60 cities across 25 provinces and administrative regions in China. Its network includes approximately 60 radiotherapy centers and over 60 diagnostic imaging centers and approximately seven centers. The Company's cooperative centers are equipped with a primary unit of medical equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, positron emission tomography-computed tomography (PET-CT) scanner or magnetic resonance imaging (MRI) scanner.